UTILISATION D'AGENTS SRSF3 POUR LE TRAITEMENT ET/OU LA PREVENTION D'AFFECTIONS NEUROLOGIQUES, DU CANCER, D'INFECTIONS BACTERIENNES OU D'INFECTIONS VIRALES
The present description relates to the use of a SRSF3 agent for regulating the function of a myeloid cell, such as a microglial cell and/or monocyte, for treating neurological conditions, cancers, bacterial infections and viral infections wherein the SRSF3 agent inhibits expression or function of SRSF3.